Performance of serum-based biomarkers in fibrosis prediction of chronic hepatitis B patients in real life practice
- 1 July 2024
- journal article
- research article
- Published by Edizioni Minerva Medica in Minerva Gastroenterology
- Vol. 70 (3) , 299-305
Abstract
Article: Performance of serum-based biomarkers in fibrosis prediction of chronic hepatitis B patients in real life practice - Minerva Gastroenterology 2023 Jun 13 - Minerva Medica - JournalsKeywords
This publication has 29 references indexed in Scilit:
- Non-alcoholic fatty liver diseaseThe Lancet, 2021
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in ChinaScientific Reports, 2017
- Evolution in Our Understanding of Hepatitis B Virus Virology and ImmunologyClinics in Liver Disease, 2016
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013The Lancet, 2015
- Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysisHepatology, 2014
- Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot studyHepatology, 2012
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicityVaccine, 2012
- Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass graftingAmerican Heart Journal, 2007
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis CGastroenterology, 2005